Shares of Mylan N.V.’s MYL were up 7.2% after the company beat expectations in the fourth-quarter 2016 and provided a strong outlook for 2017 amid challenging conditions. The company reported fourth-quarter 2016 earnings of $1.57 per …
One lower-price competitor, AdrenaClick, is not as widely available and some pharmacies that do stock the product charge around the same price as they do for EpiPen. Mylan has announced plans for a generic version of EpiPen, but the …
Daniel Zuchnik—WireImage By Julia Zorthian August 25, 2016 Actress Sarah Jessica Parker is ending her relationship with pharmaceutical giant Mylan and speaking out against ... spoke against the price hike and its stock plummeted …
A damning congressional report fresh off the press Tuesday (Sept. 20) connects the Clinton Foundation and three Indian drug companies – one of which was bought by Mylan NV (Nasdaq: MYL) a decade ago – to a humanitarian scandal…
NEW YORK (CNNMoney.com) -- Mylan Pharmaceuticals' stock plunged after the drugmaker said it was purchasing the generic arm of German drug giant Merck KGaA. Mylan (down $2.49 to $19.91, Charts) stock fell more than 13 percent …
Teva Pharmaceutical Industries, Ltd., has been trying to buy fellow giant generic drugmaker Mylan, Inc., and the latest step to emerge was the purchase of chunks of stock on the open market. Teva said it had bought a 1.35% stake in …
Mylan's shares dropped after it said that delays in launching key new drugs and lower prices for generics in the United States will hurt its profitability this and next year. Fred Katayama reports.
Of the company's shareholders who voted, 98 percent approved the transaction. Yet not all stockholders were aware of the tax implications. John Kablach, 85, of Smithton only recently found out he would have to pay capital gains on his …
(AP Photo/Mark Zaleski, File) Shares of Mylan are edging up before the opening bell after the pharmaceutical company went ahead with its hostile, $27.14 billion bid for Perrigo. With the cash and stock offer made directly to Perrigo's …
What a difference a hostile takeover bid can make. Perrigo Co. for months has been publicly trashing Mylan NV and its prospects as part of an effort to fend off a roughly $27 billion hostile bid from the Dutch company. But the concerns …